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Abstract The sequences of 41 subunits of complex I
(NADH:ubiquinone oxidoreductase) from bovine heart mito-
chondria have been described previously. Seven of them are
encoded in mitochondrial DNA, and the remainder are nuclear
gene products that are imported into the organelle from the
cytoplasm. By electrospray mass spectrometry experiments
conducted on complex I and on two related subcomplexes, an
additional protein has been identified with a mass not
corresponding to any of the known subunits of the enzyme. This
protein has also been found in samples of the enzyme fractionated
on two dimensional polyacrylamide gels. Material from these
gels has been digested with trypsin and peptide sequences have
been determined, confirming that the protein did not correspond
to any of the known subunits of complex I. The cDNA sequence
of this protein, determined with the aid of the peptide sequences,
demonstrates that it is a novel subunit of complex I, and that it is
related to a 13-kDa human protein associated with differentia-
tion.
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1. Introduction
Complex I (NADH:ubiquinone oxidoreductase) is found in
the inner membranes of mitochondria and eubacteria, and
provides the entry point for electrons from NADH into their
electron transport chains. The enzyme from bovine heart mi-
tochondria is an assembly of at least 41 di¡erent proteins that
contains one molecule of non-covalently bound FMN and
many Fe-S clusters [1]. Seven of its subunits are products of
the mitochondrial genome, and the remainder are nuclear
gene products that are imported into the organelle. These
various components have a combined molecular mass of
about 900 kDa, and because it is so large, the individual
assemblies can be visualized readily by electron microscopy.
Complex I is L-shaped, with one arm in the lipid bilayer and
the other protruding from it. The protruding globular arm
appears to become narrower close to the membrane surface
[2,3]. It can be dissociated from the membrane domain as a
water soluble assembly known as subcomplex IV that can
transfer electrons from NADH to arti¢cial acceptors such as
ferricyanide, but not to quinones [4]. Subcomplex IV contains
about 14 of the subunits of complex I, all of the known Fe-S
clusters, the non-covalently bound FMN prosthetic group,
and the NADH binding site [4,5].
By electrospray mass spectrometry experiments conducted
on complex I and on two related subcomplexes, a protein has
been identi¢ed with a mass not corresponding to any of the
known subunits of bovine complex I. The same protein has
been found in bovine complex I fractionated on two-dimen-
sional polyacrylamide gels. The sequences of tryptic peptides
were used to design synthetic mixed oligonucleotides for use
in polymerase chain reactions (PCRs) that led to complete
cDNA and protein sequences. The mature protein sequence
of the subunit, designated B17.2, contains 145 amino acids,
and has an acetylated K-amino group. Its sequence is related
to a human 13-kDa di¡erentiation associated protein.
2. Materials and methods
2.1. Materials
Complex I was puri¢ed from bovine heart mitochondria [6]. Sub-
complexes IK and IV were prepared from complex I [4,5]. Trypsin
(sequencing grade) was obtained from Boehringer Mannheim (Lewes,
UK). Aquapore and Poros R2 reverse phase chromatography col-
umns were supplied by Applied Biosystems, Warrington, UK and
PerSeptive Biosystems, Hertford, UK, respectively. Oligonucleotides
were synthesized with an Applied Biosystems 380B instrument.
2.2. Reverse-phase high pressure liquid chromatography of subunit
B17.2
Complex I, and subcomplexes IK and IV, were precipitated from
dodecyl maltoside solutions with 20-fold excesses (v/v) of ice-cold
ethanol. The suspensions were kept for 16 h at 320‡C. The precip-
itates were redissolved in 6 M guanidinium hydrochloride in 0.1%
(v/v) tri£uoroacetic acid, and the subunits were fractionated by re-
verse-phase high pressure liquid chromatography (HPLC). Chroma-
tography was conducted either on an Aquapore C8 column (300 Aî
pores, 7 W particles, 100U2.1 mm i.d.), with a Hewlett Packard
1090M liquid chromatograph, or on a Vydac C8 column (150U1.0
mm i.d.) with an Ultrafast Microprotein Analyzer (Michrom BioRe-
sources, Auburn, CA, USA). Both columns were equilibrated in 0.1%
(v/v) tri£uoroacetic acid, and developed with a linear gradient of
acetonitrile containing 0.09% (v/v) tri£uoroacetic acid. Portions of
eluates were examined by electrospray ionization mass spectrometry
(ESI-MS), either ‘o¡ line’, (from 2-mm i.d. columns), or ‘on-line’
(from 1-mm i.d. columns) [7].
2.3. Two dimensional gel analysis
The subunits of complex I were separated on two dimensional poly-
acrylamide gels [8]. The ¢rst dimension (NEPHGE) was conducted in
tube gels (170U0.75 mm i.d.) containing 2% ampholines (1.5%, pH
range 7^9, and 0.5%, pH range 3.5^10). Samples (40 Wg) dissolved in a
solution (10 Wl) containing 9.5 M urea, 2% Nonidet NP40, and 2%
ampholines (1.5%, pH 7^9, 0.5%, pH 3.5^10) were applied at the
anode end. The reservoirs contained 0.2% (v/v) orthophosphoric
acid (anode), and 0.4% (v/v) 1,2-diaminoethane (cathode). A potential
of 400 V was applied for 6 h. Then the gel was extruded into a bu¡er
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containing 0.06 M Tris-HCl, pH 6.8, 2% sodium dodecyl sulfate
(SDS), 100 mM dithiothreitol, and 10% glycerol. The gel was shaken
in this solution for 20 min and then placed on a 10^25% polyacryl-
amide gradient slab Laemmli gel (20U20 cmU0.75 mm) [9]. The
second dimension (SDS-polyacrylamide gel electrophoresis (PAGE))
was developed until the bromophenol blue marker dye had reached
the bottom of the gel.
Subunits of complex I were transferred from two dimensional gels
onto poly-(vinylidene-di£uoride) membranes [10], and proteins were
detected with PAGE blue 83 dye. Proteins in gels were stained either
with PAGE blue 83 dye, or silver [11], development being terminated
with 5% acetic acid. Spots were excised for further analysis.
2.4. Enzymic digestion of subunits and puri¢cation of peptides
Tryptic digestions were performed as described before [11], except
that gel pieces containing the B17.2 subunit were ¢rst macerated and
then digested in Tris-HCl bu¡er (20 mM, pH 8.0). Two tryptic digests
of subunit B17.2 from identical blue stained gels were combined and
fractionated by reverse phase HPLC on an Aquapore C18 column
(100U2.1 mm i.d.) equilibrated in 0.1% (v/v) tri£uoroacetic acid. Pu-
ri¢ed peptides were sequenced in an Applied Biosystems Procise 494
instrument.
An unfractionated tryptic digest of subunit B17.2 obtained from a
single silver stained spot from a two dimensional gel was freed of salts
and other impurities on Poros R2 (20 Aî pores) in a glass capillary
similar to a nanoelectrospray needle (bed volume, 50^100 nl) [11].
Peptides were applied to the column in 5% aqueous methanol con-
taining 5% formic acid (10 Wl), and the column was washed twice with
the same solvent (3 Wl). Peptides were eluted with 60% aqueous meth-
anol containing 5% formic acid (total 1 Wl) and transferred directly to
a nanoelectrospray needle.
2.5. Mass spectrometry
The molecular masses of subunits of complex I [7,12] were meas-
ured in a Perkin Elmer Sciex API III triple quadrupole mass spec-
trometer with pneumatically assisted electrospray ionization. Tandem
mass spectrometry experiments were conducted in the same instru-
ment ¢tted with a nanoelectrospray source [13], which allowed 1-Wl
samples of a tryptic digest of subunit B17.2 to be analyzed for up to
1 h, and for multiple mass measurements to be recorded. First, spectra
were recorded on the digest. Then peptide ions were distinguished
from those arising from non-peptide contaminants by subjecting
each ion in turn to collisional fragmentation with argon. The resultant
spectra were examined for the presence of immonium ions (m/z 86)
which arise from isoleucine and leucine side chains and so are diag-
nostic of peptide ions [14]. Then each peptide ion was selected, frag-
mented and its fragment ion tandem mass spectrum recorded. Partial
amino acid sequences were deduced from the tandem mass spectra.
2.6. Ampli¢cation and sequencing the cDNA for subunit B17.2
The ampli¢cation of the cDNA encoding the B17.2-kDa subunit of
bovine complex I was carried out as described previously [15,16].
First, mixtures of synthetic oligonucleotides based on the partial tryp-
tic peptide sequences KFNLSG and IQEWVP were used as primers in
a PCR with total bovine cDNA as template. The partial cDNA bridg-
ing these two sequences was detected in the reaction products by
hybridization with a third mixture of oligonucleotides based on the
sequence QQYVPY. In two further PCRs with unique primers (2F,
2R and 3R, see Fig. 2) and with oligo dT primers in the opposite
sense, the partial cDNA was sequenced and then extended to the 5P
and 3P extremities of the intact cDNA. For the 5P extension, the
template was bovine heart cDNA with a 5P poly(A) tail added with
terminal transferase [16]. DNA sequences were determined by the
modi¢ed dideoxy method [17].
3. Results and discussion
3.1. Evidence for a new subunit of complex I
During the characterization of the subunit compositions of
bovine complex I and subcomplexes IK and IV, a component
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Fig. 1. Separation of the subunits of bovine mitochondrial complex I and subcomplex IV on two dimensional gels by NEPHGE and SDS-
PAGE. A: Complex I; B: sub-complex IV. The proteins were detected by silver staining. Subunits identi¢ed by protein chemical means (see
Table 1) are indicated by their estimated molecular masses. The position of subunit B17.2 is indicated by an asterisk.
Table 1
Identi¢cation of subunits of complex I from bovine mitochondria
Subunit Method of identi¢cation
Complex I Subcomplex IV
75 kDa 1 1
51 kDa 1, 2 1
49 kDa 1, 2 1
42 kDa 1 Not present
39 kDa 1, 2 Not present
30 kDa 1, 2 1
24 kDa 1, 3 1
PSST (22) 1, 2 1
18 kDa 1, 2, 3 1
B17.2 2, 3 4
15 1, 2, 3 Not present
B13 2, 3 4
B8 3 4
Subunits of complex I and subcomplex IV were separated on two-
dimensional gels (see Fig. 1) and identi¢ed by various methods.
1: By N-terminal sequence analysis; 2: by tandem MS of tryptic
peptides; 3: by Edman degradation of tryptic peptides; 4: by refer-
ence to gel in Fig. 1A.
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with a mass of 17 208 þ 2 was observed by ESI-MS on a num-
ber of occasions. Often it was accompanied by another abun-
dant component with a mass of 17 131. Neither of these
masses corresponds to any of the 41 characterized subunits
of the enzyme. Therefore, they appeared to represent new
subunits of the enzyme. It is now evident from the data de-
scribed below that the mass of 17 131 corresponds to the K-N-
acetylated B17.2 subunit with a reduced cysteine residue, and
that the 17 208 þ 2 value arises from the same B17.2 protein
with an artefactual mercaptoethanol (+76 mass units), at-
tached by a disul¢de linkage. Mercaptoethanol adducts have
been detected before during the characterization of other com-
plex I subunits, particularly from subunit B13 [15].
Subunit B17.2 co-eluted from C18 HPLC columns with
subunits B14, B13 and MLRQ [15] at 46% acetonitrile. No
new N-terminal sequences were found in these fractions by
Edman degradation, and so subunit B17.2 appeared to have
a modi¢ed N-terminus, as have 18 other subunits of the com-
plex [15,18]. Subunit B17.2 could not be separated from these
other subunits by chromatography, and so it was puri¢ed by
two dimensional electrophoresis of complex I and its subcom-
plexes. Many subunits of bovine complex I have apparent
molecular weights in the range between 10^20 kDa and are
basic. Therefore, it was necessary to combine SDS-PAGE
with NEPHGE. As summarized in Fig. 1 and Table 1, various
subunits were identi¢ed on such gels by protein chemical
methods. One spot (labelled with an asterisk), gave rise to
tryptic peptide sequences that did not belong to any of the
known subunits of the complex. This spot contains subunit
B17.2.
3.2. The cDNA sequence of the new subunit of complex I
Three sequences obtained by Edman degradation of tryptic
peptides (see Fig. 2) were used as the basis for isolating a
partial cDNA from bovine cDNA (see Section 2, and legends
to Figs. 2 and 3). In two further PCRs, this partial cDNA
sequence was extended to the 5P and 3P extremities of the
intact cDNA (see Figs. 2 and 3). The 5P end of the cDNA
sequence (Fig. 2) terminates close to the proposed initiation
codon, and does not contain an up-stream termination codon
in phase. The protein mass calculated from the protein se-
quence is 17 131.6 Da, assuming that the N-terminal methio-
nine is acetylated in the mature protein. This value corre-
sponds to the mass measured by ESI-MS (17 130.8 Da). The
hydrophobic pro¢le (not shown) indicates that the protein is
hydrophilic and has no extensive hydrophobic sequences.
These properties are consistent with the subunit being associ-
ated with subcomplex IV which represents the globular extra-
membrane domain of complex I. Subcomplex IK contains all
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Fig. 2. Sequence of the cDNA encoding the B17.2 subunit of complex I from bovine mitochondria. The shaded regions were determined by se-
quencing tryptic peptides. The boxed sequences 1F and 1R were used to design synthetic oligonucleotide mixtures employed in an initial PCR.
The resulting partial cDNA was extended to the 3P and 5P extremities with primers based on the two boxed nucleotide sequences 2F and 3R
and primers complementary to poly(A) and poly(G) sequences at the 3P and 5P ends [16]. The senses of the primers are indicated by arrows. A
polyadenylation signal is underlined twice.
Fig. 3. Generation by PCR and sequence analysis of the cDNA
clones encoding the B17.2 subunit of complex I from bovine heart
mitochondria. PCRs 1^3 denote the cloned partial cDNAs generated
by PCRs. The heavy lines represent the cDNA fragments, and the
arrowed lines indicate the directions and extents of the determined
sequences.
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the subunits in subcomplex IV and four additional hydropho-
bic subunits. Subunit B17.2 is the 18th nuclear coded subunit
of complex I that evidently lacks a cleavable presequence to
direct its import into the mitochondrion.
3.3. The N-terminus of subunit B17.2 is acetylated
The m/z values of two ions (586.6 and 594.6) observed in
tandem mass spectrometry (MS) experiments on tryptic pep-
tides of B17.2 correspond to forms of the N-terminal tryptic
peptide (Ac-MELLQVLKR), with reduced and oxidized me-
thionines, respectively. From the fragment ion spectrum of a
doubly charged ion of m/z 586.6 (Fig. 4), the amino acid
sequence E-I/L-I/L-Q/K-V-I/L-Q/K, R was deduced from a
series of Y ion fragments [19], demonstrating that the peptide
is the N-terminal fragment of B17.2. Its mass (MH 1172.2),
and the fragment ions B1 (m/z 174) and B2 (m/z 303), corre-
sponding to Ac-M and Ac-ME, show that the N-terminal
methionine is acetylated. An expanded region of the fragment
ion (see inset in Fig. 4) distinguishes the B1 ion (m/z 174) from
the C-terminal arginine Y1 ion (m/z 175).
3.4. Homology of bovine B17.2 with a human protein
Residues 70^132 of subunit B17.2 of bovine complex I are
70% identical to a human 13-kDa protein, in the NCBI non-
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Fig. 4. Fragment ion spectrum obtained by tandem mass spectrometry of the N-terminal tryptic peptide of subunit B17.2 of bovine complex I.
A doubly charged ion (m/z 586.6) was selected and collided with argon gas with a collision energy of 40 eV. The inset contains an expanded re-
gion of the spectrum from m/z 168^180. The Y fragment ions [19] were interpreted as a partial amino acid sequence, as indicated. The pre-
dicted nominal masses of B and Y ions are also indicated. Ac-M is N-acetylmethionine.
Fig. 5. Alignment of the sequences of the B17.2 subunit of bovine complex I and a 13-kDa human ‘di¡erentiation protein’. Colons denote resi-
dues that are identical in both sequences.
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redundant database (accession number 995939; see Fig. 5).
Little is known about the human protein, except that it is
described as a theoretical product of a gene identi¢ed in an
adenocarcinoma cell line which had been induced to di¡er-
entiate by treatment with all trans-retinoic acid. For this rea-
son, the gene and its product are described as being ‘di¡er-
entiation associated’. It is possible that the 13-kDa protein is
part of the B17.2 kDa homologue in human complex I.
3.5. Subunit composition of complex I
The B17.2 subunit is the 42nd subunit to be sequenced from
bovine mitochondrial complex I. From time to time, another
component with a molecular mass of 10 566 þ 2 Da has been
observed in ESI-MS experiments carried out on complex I
and subcomplex IL [12]. This protein has not been sequenced
yet, but it is likely to be the 43rd and ¢nal subunit of the
complex.
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